5 Recruiting Metastatic Pancreatic Ductal Adenocarcinoma Phase 1 Clinical Trials

Active phase 1 studies for metastatic pancreatic ductal adenocarcinoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Metastatic Pancreatic Ductal Adenocarcinoma studies

Phase 1 Studies for Metastatic Pancreatic Ductal Adenocarcinoma

🔵 Active, Not Recruiting Phase1 / Phase2

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase1

Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma

📍 Cedars-Sinai Cancer at SOCC — Los Angeles, California

View Study & Checklist ➔

🟢 Recruiting Phase1

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

📍 Washington University School of Medicine — St Louis, Missouri

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

📍 Washington University School of Medicine — St Louis, Missouri

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

📍 Roswell Park Cancer Institute — Buffalo, New York

View Study & Checklist ➔